We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sinusitis

News List

FDA Approves First Drug for Sinusitis With Nasal Polyps, Dupixent (Dupilumab) drugs
June 28, 2019
FDA Approves First Drug for Sinusitis With Nasal Polyps, Dupixent (Dupilumab).
On a roll, Dupixent marches into teen eczema, nabs fast FDA review in sinusitis fiercepharma
March 13, 2019
Sanofi and Regeneron’s next-gen immunology drug Dupixent is on fire. Already on its way to blockbusterland after grabbing a key asthma nod last October, the drug scored two back-to-back regulatory wins at the FDA.
NICE warns against blanket use of antibiotics to treat sinus infections pharmatimes
October 30, 2017
The National Institute for Health and Care Excellence is warning against blanket use of antibiotics to treat sinus infections.